Researchers from The University of Texas MD Anderson Cancer Center will present initial data from six clinical trials during minisymposia at this week’s American Association for Cancer Research (AACR) ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will share six abstracts, including two podium presentations, at the American ...
In this conference report from ABRF 2026, the authors reflect on the meeting's insights into core facility research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results